During the past decade, Infectious Diseases Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Infectious Diseases Associates" #1 sponsor was "Agouron Pharmaceuticals" with 3 trials, followed by "EMD Serono" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Glaxo Wellcome" with 1 trials sponsored and "Schering-Plough" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

According to Clinical.Site data, the most researched conditions in "Infectious Diseases Associates" are "HIV Infections" (10 trials), "Lipodystrophy" (2 trials) and "Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome" (1 trials). Many other conditions were trialed in "Infectious Diseases Associates" in a lesser frequency.

Most popular intervention types in "Infectious Diseases Associates" are "Drug" (10 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nelfinavir mesylate" (5 trials), "Capravirine" (3 trials), "Lamivudine/Zidovudine" (2 trials), "Abacavir sulfate" (1 trials) and "Atazanavir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Infectious Diseases Associates" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Infectious Diseases Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Infectious Diseases Associates, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Infectious Diseases Associates, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".